Selected research
Market Structure
Global Diabetes Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Diabetes Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Diabetes Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Diabetes Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Diabetes Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Diabetes Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Diabetes Screening include InSphero AG, Abbott Laboratories, American Laboratory Products Company (ALPCO), Beckmann Coulter Inc., Bio-Rad Laboratories Inc., Ortho Clinical Diagnostics Inc., F. Hoffmann-la Roche Ltd, Siemens AG and PTS Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Diabetes Screening market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Diabetes Screening and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Diabetes Screening revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Diabetes Screening market size, projected growth trends, production technologies, key applications, and end-use industries.
Diabetes Screening Segment by Company
InSphero AG
Abbott Laboratories
American Laboratory Products Company (ALPCO)
Beckmann Coulter Inc.
Bio-Rad Laboratories Inc.
Ortho Clinical Diagnostics Inc.
F. Hoffmann-la Roche Ltd
Siemens AG
PTS Diagnostics
Diabetes Screening Segment by Type
Instrument
Test Suite
Reagents
Diabetes Screening Segment by Application
Hospital
Specialty Clinic
Diagnostic Center
Home Care
Academic Research Institution
Diabetes Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetes Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetes Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetes Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Diabetes Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Diabetes Screening industry.
Chapter 3: Detailed analysis of Diabetes Screening companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Screeningrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Instrument
- Test Suite
- Reagents
Applications
- Hospital
- Specialty Clinic
- Diagnostic Center
- Home Care
- Academic Research Institution
Companies covered
- InSphero AG
- Abbott Laboratories
- American Laboratory Products Company (ALPCO)
- Beckmann Coulter Inc.
- Bio-Rad Laboratories Inc.
- Ortho Clinical Diagnostics Inc.
- F. Hoffmann-la Roche Ltd
- Siemens AG
- PTS Diagnostics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Diabetes Screening Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Instrument
- 1.2.3 Test Suite
- 1.2.4 Reagents
- 1.3 Market Analysis by Application
- 1.3.1 Global Diabetes Screening Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Specialty Clinic
- 1.3.4 Diagnostic Center
- 1.3.5 Home Care
- 1.3.6 Academic Research Institution
- 1.4 Global Market Growth Prospects
- 1.5 Global Diabetes Screening Growth Trends by Region
- 1.5.1 Global Diabetes Screening Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Diabetes Screening Market Size by Region (2021-2026)
- 1.5.3 Diabetes Screening Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Diabetes Screening Market Dynamics
- 2.1 Diabetes Screening Industry Trends
- 2.2 Diabetes Screening Industry Drivers
- 2.3 Diabetes Screening Industry Opportunities and Challenges
- 2.4 Diabetes Screening Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Diabetes Screening Revenue by Company (2021-2026)
- 3.2 Global Diabetes Screening Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Diabetes Screening Key Company Head office and Area Served
- 3.4 Global Diabetes Screening Company, Product Type & Application
- 3.5 Global Diabetes Screening Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Diabetes Screening Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Diabetes Screening Players Market Share by Revenue in 2025
- 3.6.3 2025 Diabetes Screening Tier 1, Tier 2, and Tier 3
4 Diabetes Screening Market by Type
- 4.1 Global Diabetes Screening Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Diabetes Screening Market Size by Type (2021-2032)
- 4.3 Global Diabetes Screening Market Size Share by Type (2021-2032)
5 Diabetes Screening Market by Application
- 5.1 Global Diabetes Screening Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Diabetes Screening Market Size by Application (2021-2032)
- 5.3 Global Diabetes Screening Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 InSphero AG
- 6.1.1 InSphero AG Company Information
- 6.1.2 InSphero AG Business Overview
- 6.1.3 InSphero AG Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 InSphero AG Diabetes Screening Product Portfolio
- 6.1.5 InSphero AG Recent Developments
- 6.2 Abbott Laboratories
- 6.2.1 Abbott Laboratories Company Information
- 6.2.2 Abbott Laboratories Business Overview
- 6.2.3 Abbott Laboratories Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Abbott Laboratories Diabetes Screening Product Portfolio
- 6.2.5 Abbott Laboratories Recent Developments
- 6.3 American Laboratory Products Company (ALPCO)
- 6.3.1 American Laboratory Products Company (ALPCO) Company Information
- 6.3.2 American Laboratory Products Company (ALPCO) Business Overview
- 6.3.3 American Laboratory Products Company (ALPCO) Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 American Laboratory Products Company (ALPCO) Diabetes Screening Product Portfolio
- 6.3.5 American Laboratory Products Company (ALPCO) Recent Developments
- 6.4 Beckmann Coulter Inc.
- 6.4.1 Beckmann Coulter Inc. Company Information
- 6.4.2 Beckmann Coulter Inc. Business Overview
- 6.4.3 Beckmann Coulter Inc. Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Beckmann Coulter Inc. Diabetes Screening Product Portfolio
- 6.4.5 Beckmann Coulter Inc. Recent Developments
- 6.5 Bio-Rad Laboratories Inc.
- 6.5.1 Bio-Rad Laboratories Inc. Company Information
- 6.5.2 Bio-Rad Laboratories Inc. Business Overview
- 6.5.3 Bio-Rad Laboratories Inc. Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Bio-Rad Laboratories Inc. Diabetes Screening Product Portfolio
- 6.5.5 Bio-Rad Laboratories Inc. Recent Developments
- 6.6 Ortho Clinical Diagnostics Inc.
- 6.6.1 Ortho Clinical Diagnostics Inc. Company Information
- 6.6.2 Ortho Clinical Diagnostics Inc. Business Overview
- 6.6.3 Ortho Clinical Diagnostics Inc. Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Ortho Clinical Diagnostics Inc. Diabetes Screening Product Portfolio
- 6.6.5 Ortho Clinical Diagnostics Inc. Recent Developments
- 6.7 F. Hoffmann-la Roche Ltd
- 6.7.1 F. Hoffmann-la Roche Ltd Company Information
- 6.7.2 F. Hoffmann-la Roche Ltd Business Overview
- 6.7.3 F. Hoffmann-la Roche Ltd Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 F. Hoffmann-la Roche Ltd Diabetes Screening Product Portfolio
- 6.7.5 F. Hoffmann-la Roche Ltd Recent Developments
- 6.8 Siemens AG
- 6.8.1 Siemens AG Company Information
- 6.8.2 Siemens AG Business Overview
- 6.8.3 Siemens AG Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Siemens AG Diabetes Screening Product Portfolio
- 6.8.5 Siemens AG Recent Developments
- 6.9 PTS Diagnostics
- 6.9.1 PTS Diagnostics Company Information
- 6.9.2 PTS Diagnostics Business Overview
- 6.9.3 PTS Diagnostics Diabetes Screening Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 PTS Diagnostics Diabetes Screening Product Portfolio
- 6.9.5 PTS Diagnostics Recent Developments
7 North America
- 7.1 North America Diabetes Screening Market Size (2021-2032)
- 7.2 North America Diabetes Screening Market Size by Type
- 7.2.1 North America Diabetes Screening Market Size by Type (2021-2026)
- 7.2.2 North America Diabetes Screening Market Size by Type (2027-2032)
- 7.2.3 North America Diabetes Screening Market Share by Type (2021-2032)
- 7.3 North America Diabetes Screening Market Size by Application
- 7.3.1 North America Diabetes Screening Market Size by Application (2021-2026)
- 7.3.2 North America Diabetes Screening Market Size by Application (2027-2032)
- 7.3.3 North America Diabetes Screening Market Share by Application (2021-2032)
- 7.4 North America Diabetes Screening Market Size by Country
- 7.4.1 North America Diabetes Screening Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Diabetes Screening Market Size by Country (2021-2026)
- 7.4.3 North America Diabetes Screening Market Size by Country (2027-2032)
- 7.4.4 North America Diabetes Screening Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Diabetes Screening Market Size (2021-2032)
- 8.2 Europe Diabetes Screening Market Size by Type
- 8.2.1 Europe Diabetes Screening Market Size by Type (2021-2026)
- 8.2.2 Europe Diabetes Screening Market Size by Type (2027-2032)
- 8.2.3 Europe Diabetes Screening Market Share by Type (2021-2032)
- 8.3 Europe Diabetes Screening Market Size by Application
- 8.3.1 Europe Diabetes Screening Market Size by Application (2021-2026)
- 8.3.2 Europe Diabetes Screening Market Size by Application (2027-2032)
- 8.3.3 Europe Diabetes Screening Market Share by Application (2021-2032)
- 8.4 Europe Diabetes Screening Market Size by Country
- 8.4.1 Europe Diabetes Screening Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Diabetes Screening Market Size by Country (2021-2026)
- 8.4.3 Europe Diabetes Screening Market Size by Country (2027-2032)
- 8.4.4 Europe Diabetes Screening Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Diabetes Screening Market Size (2021-2032)
- 9.2 China Diabetes Screening Market Size by Type
- 9.2.1 China Diabetes Screening Market Size by Type (2021-2026)
- 9.2.2 China Diabetes Screening Market Size by Type (2027-2032)
- 9.2.3 China Diabetes Screening Market Share by Type (2021-2032)
- 9.3 China Diabetes Screening Market Size by Application
- 9.3.1 China Diabetes Screening Market Size by Application (2021-2026)
- 9.3.2 China Diabetes Screening Market Size by Application (2027-2032)
- 9.3.3 China Diabetes Screening Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Diabetes Screening Market Size (2021-2032)
- 10.2 Asia Diabetes Screening Market Size by Type
- 10.2.1 Asia Diabetes Screening Market Size by Type (2021-2026)
- 10.2.2 Asia Diabetes Screening Market Size by Type (2027-2032)
- 10.2.3 Asia Diabetes Screening Market Share by Type (2021-2032)
- 10.3 Asia Diabetes Screening Market Size by Application
- 10.3.1 Asia Diabetes Screening Market Size by Application (2021-2026)
- 10.3.2 Asia Diabetes Screening Market Size by Application (2027-2032)
- 10.3.3 Asia Diabetes Screening Market Share by Application (2021-2032)
- 10.4 Asia Diabetes Screening Market Size by Country
- 10.4.1 Asia Diabetes Screening Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Diabetes Screening Market Size by Country (2021-2026)
- 10.4.3 Asia Diabetes Screening Market Size by Country (2027-2032)
- 10.4.4 Asia Diabetes Screening Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Diabetes Screening Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Diabetes Screening Market Size by Type
- 11.2.1 South America, Middle East & Africa Diabetes Screening Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Diabetes Screening Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Diabetes Screening Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Diabetes Screening Market Size by Application
- 11.3.1 South America, Middle East & Africa Diabetes Screening Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Diabetes Screening Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Diabetes Screening Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Diabetes Screening Market Size by Country
- 11.4.1 South America, Middle East & Africa Diabetes Screening Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Diabetes Screening Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Diabetes Screening Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Diabetes Screening Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst